Related Experiment Videos
A vaccinia replication system for producing recombinant hepatitis C virus.
Ying-Song Wu1, Yu Feng, Wen-Qi Dong
1Institute of Tropical Medicine, First Military Medical University, Guangzhou 510515, Guangdong Province, China.
World Journal of Gastroenterology
|August 17, 2004
Summary
Researchers developed a novel cell culture system to produce high-titer hepatitis C virus (HCV) stocks using recombinant vaccinia viruses. This method significantly enhances recombinant HCV yield for virology research.
Area of Science:
- Virology
- Molecular Biology
- Cell Culture
Background:
- Hepatitis C virus (HCV) research is hindered by challenges in generating sufficient viral stocks.
- Existing methods for producing recombinant HCV have limitations in yield and efficiency.
Purpose of the Study:
- To establish a robust cell culture system for high-titer production of recombinant hepatitis C virus (HCV).
- To utilize recombinant vaccinia viruses as helper systems to enhance HCV replication and yield.
Main Methods:
- Generation of recombinant HCV involved two plasmids: one with full-length HCV cDNA and another with the HCV polyprotein open reading frame (ORF).
- Co-transfection into BHK21 cells followed by infection with vTF7-3 recombinant vaccinia helper viruses.
- Quantification of HCV RNA using fluorescence quantitative RT-PCR (FQ-PCR).
Main Results:
- Achieved approximately 3.6 x 10^7 copies of HCV RNA per milliliter of cell culture supernatant after 5 days.
- Demonstrated a 100- to 1,000-fold increase in recombinant HCV yield compared to previous methods.
- Validated the efficiency of the recombinant vaccinia virus helper system.
Conclusions:
- The developed cell culture system effectively produces high-titer recombinant HCV stocks.
- This system offers a significant advancement for HCV research, enabling better study of viral replication and pathogenesis.
- Provides a reliable platform for generating substantial amounts of infectious HCV for experimental purposes.